Sanofi to acquire US biopharma firm Blueprint Medicines
MLex Summary: Sanofi has agreed to buy Blueprint Medicines for about $9.5 billion. Sanofi currently expects to complete the acquisition in the third quarter of 2025.See full statement....To view the full article, register now.
Already a subscriber? Click here to view full article